Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Given the proinflammatory nature of the SASP, it is not surprising that senescent cells can attract immune cells, including destructive leukocytes of the innate and adaptive immune systems (131, 132, 135).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Among the cells that participate in the clearance of senescent cells are natural killer cells, macrophages, and T cells (131, 135, 139).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Senescent cells, presumably by virtue of SASP-derived factors, can stimulate the infiltration of leukocytes (93, 131, 132), which produce reactive toxic moieties that can cause DNA damage.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“Another function appears to be the stimulation of a local immune reaction to eliminate oncogene-expressing cells, both those cells that have undergone oncogene-induced senescence and those oncogene-transformed cells that have bypassed or escaped senescence (131).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [131]
In the citing paper
“The surveillance and clearance of senescent cells by the immune system is necessary in order to limit tumorigenesis in premalignant lesions and following cancer therapy155,156,159.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [156]
39 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Self-citationKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Khwaja, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2783 · Cited by 1,039
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Silva, M. T. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0809549 · Cited by 322
Cited by
Items 401–500 of 1,009
F4/80+ macrophages contribute to clearance of senescent cells in the mouse postpartum uterus
Egashira, M., Hirota, Y., Shimizu-Hirota, R., Saito-Fujita, T., Haraguchi, H., Matsumoto, L., Matsuo, M., Hiraoka, T., Tanaka, T., Akaeda, S., et al. (2017) · Endocrinology · doi:10.1210/en.2016-1886 · Cited by 90
Korbecki, J., Gąssowska-Dobrowolska, M., Wójcik, J., Szatkowska, I., Barczak, K., Chlubek, M., & Baranowska‐Bosiacka, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084205 · Cited by 99
“Such a cell exhibits the so-called senescenceassociated secretory phenotype (SASP), important in the recognition of the cell by the immune system cells, in particular natural killer (NK) cells [43] and CD4+ T cells [44].”
BackgroundCellular Senescence: Mechanisms and Therapeutic Potential
Liao, Z., Yeo, H. L., Wong, S. W., & Zhao, Y. X. (2021) · Biomedicines · doi:10.3390/biomedicines9121769 · Cited by 94
“Some components which are produced in the SASP of senescent cells attract and signal cells of the immune system, such as macrophages, which help to detect and eliminate the senescent cells in programmed senescence, such as the anti-tumourigenic response [30].”
BackgroundCellular senescence links mitochondria-ER contacts and aging
Ziegler, D. V., Martin, N., & Bernard, D. (2021) · Communications Biology · doi:10.1038/s42003-021-02840-5 · Cited by 100
Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools
Knoppert, S. N., Valentijn, F. A., Nguyen, T. Q., Goldschmeding, R., & Falke, L. L. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00770 · Cited by 83
“Although the precise mechanism by which metformin attenuates age-related disease is unknown, it is suggested that metformin inhibits NF-κB signaling, thus inhibiting SASP (Moiseeva et al., 2013; Noren Hooten et al., 2016; Kanigur Sultuybek et al., 2019).”
BackgroundShahbandi, A., Chiu, F.-Y., Ungerleider, N. A., Kvadas, R., Mheidly, Z., Sun, M. J. S., Tian, D., Waizman, D. A., Anderson, A. Y., Machado, H. L., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00466-y · Cited by 83
Sun, X., Han, L., Seth, P., Bian, S., Li, L., Csizmadia, E., Junger, W. G., Schmelzle, M., Usheva, A., Tapper, E. B., et al. (2013) · Hepatology · doi:10.1002/hep.25989 · Cited by 87
“Recent studies have also noted that murine hepatocytes enter a senescence program triggered by excessive proliferative signaling, which has features (at least in part) of the cellular phenotype observed in these current studies in Cd39-null hepatocytes.(31) Senescent liver cells are subject to surveillance and immune…”
BackgroundVervloessem, T., Yule, D. I., Bultynck, G., & Parys, J. B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.12.006 · Cited by 97
“For instance, in pre-malignant hepatocytes, senescence led to the secretion of chemo- and cytokines, resulting in their clearance by CD4+ T cells [187].”
BackgroundDormant cancer cells: programmed quiescence, senescence, or both?
Truskowski, K., Amend, S. R., & Pienta, K. J. (2023) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10073-z · Cited by 92
Current senolytics: Mode of action, efficacy and limitations, and their future
Rad, A. N., & Grillari, J. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111888 · Cited by 83
“…cells have a variety of beneficial, physiological roles including in wound healing (Demaria et al., 2014), oncogenesis surveillance (Campisi, 2005; Kang et al., 2011), immunogenicity (Marin et al., 2023), embryogenesis (Mu ˜ noz-Espín et al., 2013), and cellular reprogramming (von Joest et al.,…”
BackgroundSASP regulation by noncoding RNA
Panda, A. C., Abdelmohsen, K., & Gorospe, M. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.05.004 · Cited by 86
Mazzoni, M., Mauro, G., Erreni, M., Romeo, P., Minna, E., Vizioli, M. G., Belgiovine, C., Rizzetti, M. G., Pagliardini, S., Avigni, R., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1198-8 · Cited by 91
Liu, B., Peng, Z., Zhang, H., Zhang, N., Liu, Z., Xia, Z., Huang, S., Luo, P., & Cheng, Q. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02284-z · Cited by 105
Tumor regulation of the tissue environment in the liver
Eggert, T., & Greten, T. F. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.005 · Cited by 93
Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy.
Saleh, T., Tyutynuk-Massey, L., Cudjoe, E. K., Idowu, M. O., Landry, J. W., & Gewirtz, D. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00164 · Cited by 85
“However, the consequences of TIS to the anti-tumor immune response are less well characterized, largely due to difficulties in generating a pure population of senescent cells to study, in contrast to OIS, which has been studied in multiple contexts and has been reviewed extensively (104).”
BackgroundInfluentialDetection of senescence using machine learning algorithms based on nuclear features
Duran, I., Pombo, J., Sun, B., Gallage, S., Kudo, H., McHugh, D., Bousset, L., Barragan Avila, J. E., Forlano, R., Manousou, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45421-w · Cited by 85
“To evaluate the tissue senescence score, we transduced constructs co-expressing GFP with oncogenic NRas (NRas G12V , referred to as G12V) or an effector loop mutant (NRas G12V,D38A , referred to as D38A) incapable of signaling downstream and induce senescence 35 (Fig.”
Self-citationSenescence-Associated Pro-inflammatory Cytokines and Tumor Cell Plasticity
Vernot, J. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00063 · Cited by 86
Exploiting tumor cell senescence in anticancer therapy
Lee, M., & Lee, J.-S. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.2.005 · Cited by 83
Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2018) · Biogerontology · doi:10.1007/s10522-018-9762-8 · Cited by 84
“Many pathological conditions involving inflammation increase the level of circulating CSFs and chemokines which stimulate the myelopoiesis and the generation of immature MDSCs.”
BackgroundInfluentialSuppression of p16 alleviates the senescence-associated secretory phenotype
(2021) · doi:10.18632/aging.202640 · Cited by 84
“senescence surveillance by immune cells [47, 95], thereby promoting tumorigenesis.”
BackgroundPallis, A. G., Hatse, S., Brouwers, B. A. H., Pawelec, G., Falandry, C., Wedding, U., Lago, L. D., Repetto, L., Ring, A. E., & Wildiers, H. P. M. W. (2013) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2013.09.001 · Cited by 90
“Clearance of the damaged cells by these infiltrating immune cells results in tumor surveillance, which seems to make the SASP a predominantly anti-tumor mechanism.(34,35) However, it has also been described that this secretory profile influences the microenvironment around these cells in such a way that it can paradox…”
BackgroundOgata, Y., Yamada, T., Hasegawa, S., Sanada, A., Iwata, Y., Arima, M., Nakata, S., Sugiura, K., & Akamatsu, H. (2021) · Experimental Dermatology · doi:10.1111/exd.14205 · Cited by 76
Cellular Senescence in Sarcopenia: Possible Mechanisms and Therapeutic Potential
He, Y., Xie, W., Li, H., Jin, H., Zhang, Y., & Li, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.793088 · Cited by 95
Menendez, J. A., Cufí, S., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., Vellon, L., & Vazquez-Martin, A. (2011) · Aging · doi:10.18632/aging.100407 · Cited by 85
“Accordingly, impaired immune surveillance of premalignant senescent hepatocytes results in the development of hepatocellular carcinomas, thus showing that senescence surveillance is important for tumor suppression in vivo by mounting specific immune responses against antigens expressed in pre-malignant senescent cells…”
BackgroundInfluentialDual Role of the Adaptive Immune System in Liver Injury and Hepatocellular Carcinoma Development
Endig, J., Buitrago‐Molina, L. E., Marhenke, S., Reisinger, F., Saborowski, A. L., Schuett, J., Limbourg, F. P., Koenecke, C., Schreder, A., Michael, A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.009 · Cited by 84
Self-citationRole of lymphocytes in liver cancer
Mossanen, J. C., & Tacke, F. (2013) · OncoImmunology · doi:10.4161/onci.26468 · Cited by 83
“Among these, CD4 T H 1 cells were identified to trigger the clearance of senescent hepatocytes, a process that relied on freshly replenished macrophages .(31) In view of the long-standing controversy on the role of T cell-dependent immunosurveillance, these data suggest that cellular senescence might be necessary for…”
Self-citationCellular senescence: a hitchhiker’s guide
Aravinthan, A. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 72
“In addition, senescent cells are also subject to immune-mediated clearance facilitated by SASP factors [165, 166].”
BackgroundIs cellular senescence an example of antagonistic pleiotropy?
Giaimo, S., & d’Adda di Fagagna, F. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00807.x · Cited by 77
Mitochondria and cellular senescence: Implications for musculoskeletal ageing
Habiballa, L., Salmonowicz, H., & Passos, J. F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.417 · Cited by 82
Mitochondrial DNA damage induces apoptosis in senescent cells
Laberge, R.-M., Adler, D., DeMaria, M., Mechtouf, N., Teachenor, R., Cardin, G. B., Desprez, P.-Y., Campisi, J., & Rodier, F. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.199 · Cited by 82
Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers
Kielbassa, K., Vegna, S., Ramirez, C., & Akkari, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02215 · Cited by 80
“tailored to the type of senescence generated in the liver TIME (159).”
BackgroundCellular Plasticity: A Route to Senescence Exit and Tumorigenesis
De Blander, H., Morel, A.-P., Senaratne, A. P., Ouzounova, M., & Puisieux, A. (2021) · Cancers · doi:10.3390/cancers13184561 · Cited by 72
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 97
“[158] Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al.”
BackgroundCellular Senescence and Vascular Disease: Novel Routes to Better Understanding and Therapy
Yin, H., & Pickering, J. G. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.051 · Cited by 82
Steatohepatitis Impairs T-cell–Directed Immunotherapies Against Liver Tumors in Mice
Heinrich, B., Brown, Z. J., Diggs, L. P., Vormehr, M., Ma, C., Subramanyam, V., Rosato, U., Ruf, B., Walz, J. S., McVey, J. C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.031 · Cited by 82
Short-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
“Indeed, a fraction of the OIS hepatocytes appears to express a higher level of MHCII, which, although not sufficient (i.e., professional APCs are necessary), is required for senescence surveillance (Kang et al. 2011).”
BackgroundInfluentialCaveolin-1, a master regulator of cellular senescence
Volonté, D., & Galbiati, F. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09875-w · Cited by 84
“Finally, chemokines and cytokines, which are secreted by senescent cells, inhibit tumor development by activating immune surveillance and promoting clearance of pre-neoplastic and cancer cells [96].”
BackgroundZhao, H., Bauzon, F., Fu, H., Lu, Z., Cui, J., Nakayama, K., Nakayama, K. I., Locker, J. D., & Zhu, L. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.021 · Cited by 80
“Recent evidence shows that oncogenic Nras induced senescence in hepatocytes to induce liver cancer when the senescence cells were not cleared (Kang et al., 2011) and that DOX treated Wnt1-induced mammary tumors more effectively in the absence of p53 induced cellular senescence than in its presence…”
Zhao, L., Hu, K., Cao, J., Wang, P., Li, J., Zeng, K., He, X., Tu, P., Tong, T., & Han, L. (2019) · Aging · doi:10.18632/aging.102240 · Cited by 83
Cellular senescence in brain aging and cognitive decline
Shafqat, A., Khan, S., Omer, M. H., Niaz, M., Albalkhi, I., AlKattan, K. M., Yaqinuddin, A., Tchkonia, T., Kirkland, J. L., & Hashmi, S. K. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1281581 · Cited by 86
“'Senescence surveillance’ was introduced by Kang and colleagues when they observed that senescent pre-malignant hepatocytes secreted a SASP that recruited CD4 + T-cells, which cleared these SCs (Kang et al., 2011).”
BackgroundSelf-citationIGFBP7 Deletion Promotes Hepatocellular Carcinoma
Akiel, M., Guo, C., Li, X., Rajasekaran, D., Mendoza, R. G., Robertson, C. L., Jariwala, N. H., Yuan, F., Subler, M. A., Windle, J. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2885 · Cited by 93
“Induction of senescence in pre-malignant cells and clearing of these senescent cells by immune system serves as a mechanism of inhibition of HCC (35).”
BackgroundHu, Q., Peng, J., Jiang, L., Li, W., Su, Q., Zhang, J., Li, H., Song, M., Cheng, B., Xia, J., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03126-0 · Cited by 90
Bustos, S. O., Antunes, F., Rangel, M. C., & Chammas, R. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.606436 · Cited by 82
“Moreover, several studies in different cell types endorsed the connection between these processes, but the mechanisms are not completely understood and occasionally contradictory, making it crucial to assess what type of autophagy program has been activated (75, 76).”
BackgroundTargeting senescent cells to attenuate cardiovascular disease progression
Song, P., Zhao, Q., & Zou, M.-H. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101072 · Cited by 76
“Senescent cells may express specific surface antigens, such as major histocompatibility complex class II (MHCII) molecules that will be recognized by distinct cells (such as CD4 + T) of the immune system and subsequently killed (Kang et al., 2011).”
BackgroundRapamycin improves healthspan but not inflammaging in nfκb1−/− mice
Correia‐Melo, C., Birch, J., Fielder, E., Rahmatika, D., Taylor, J., Chapman, J., Lagnado, A., Carroll, B. M., Miwa, S., Richardson, G., et al. (2019) · Aging Cell · doi:10.1111/acel.12882 · Cited by 77
“The SASP can have beneficial effects such as the facilitation of immune surveillance and the clearance of senescent cells (Kang et al., 2011).”
BackgroundChromosomal instability-induced senescence potentiates cell non-autonomous tumourigenic effects
He, Q., Au, B., Kulkarni, M., Shen, Y., Lim, K. J., Maimaiti, J., Wong, C. K., Luijten, M. N. H., Chong, H. C., Lim, E. H., et al. (2018) · Oncogenesis · doi:10.1038/s41389-018-0072-4 · Cited by 68
“Depending on the context and target cells, the SASP can have tumour-suppressing capabilities by activating the immune response (251-253, 256), inducing paracrine senescence (257, 258) or enforcing senescence in an autocrine manner (205, 206, 259).”
BackgroundResultThe senescence journey in cancer immunoediting
Zingoni, A., Antonangeli, F., Sozzani, S., Santoni, A., Cippitelli, M., & Soriani, A. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01973-5 · Cited by 84
“In particular, CCR2 + myeloid cells are recruited into the tumor bed and a CD4 + T cell-mediated response stimulates macrophages to clear pre-malignant SnCs [39, 40].”
BackgroundImmune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation
Kansara, M., Leong, H. S., Lin, D. M., Popkiss, S., Pang, P., Garsed, D. W., Walkley, C. R., Cullinane, C., Ellul, J., Haynes, N. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70559 · Cited by 77
“SASP engage a host-dependent cellular immune response (51).”
BackgroundHuang, Y., Yang, X. F., Meng, Y., Shao, C., Liao, J., Li, F., Li, R., Jing, Y., & Huang, A. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00683-5 · Cited by 82
“Activated immune cells, including macrophages, might contribute to the elimination of precancerous senescent hepatocytes, inducing their immune-mediated clearance to prevent tumor initiation, a process termed ‘‘senescence surveillance’’ [11, 17].”
BackgroundTGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state
Matsuda, S., Revandkar, A., Dubash, T. D., Ravi, A., Wittner, B. S., Lin, M., Morris, R. T., Burr, R., Guo, H., Seeger, K., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112129 · Cited by 84
“54 The SASP can also support an immune-suppressive environment to promote tumor progression through recruitment of myeloid cells, which suppress NK cells, 18 or myeloid-derived suppressor cells that prevent CD4 + , CD8 + , and NK cell expansion.”
Siglec‐h on activated microglia for recognition and engulfment of glioma cells
Kopatz, J., Beutner, C., Welle, K., Bodea, L. G., Reinhardt, J., Claude, J., Linnartz‐Gerlach, B., & Neumann, H. (2013) · Glia · doi:10.1002/glia.22501 · Cited by 72
“Senescent or aged cells have an altered phenotype including changes in their cytokine production (Kang et al., 2011) and in their glycocalyx (Dall’olio et al.”
BackgroundComprehensive assessment of cellular senescence in the tumor microenvironment
Wang, X., Ma, L., Pei, X., Wang, H., Tang, X., Pei, J.-F., Ding, Y.-N., Qu, S., Wei, Z.-Y., Wang, H.-Y., et al. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac118 · Cited by 76
Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma
Zheng, C., Snow, B. E., Elia, A. J., Nechanitzky, R., Dominguez-Brauer, C., Liu, S., Tong, Y., Cox, M. A., Focaccia, E., Wakeham, A. C., et al. (2023) · Nature Cancer · doi:10.1038/s43018-023-00624-w · Cited by 75
“The immune system plays a dual role in liver cancer and can sense and eliminate preneoplastic and malignant hepatocytes 5,6 ; it can also promote the selection of tumor cells and favor cancer progression in situations of chronic inflammation or immunosuppression 7–9 .”
BackgroundcGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy
Long, Z., Wang, J., Xu, J., Lei, X., & Liu, Q. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.044 · Cited by 78
PLA2R1: Expression and function in cancer
Bernard, D., & Vindrieux, D. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.03.003 · Cited by 78
“Genetic events encouraging senescence escape are thus expected to promote cancer initiation and progression [8,13,21,27].”
BackgroundSTAT3 Regulates the Onset of Oxidant-induced Senescence in Lung Fibroblasts
Waters, D. W., Blokland, K. E. C., Pathinayake, P. S., Wei, L., Schuliga, M. J., Jaffar, J., Westall, G. P., Hansbro, P. M., Prêle, C. M., Mutsaers, S. E., et al. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2018-0328oc · Cited by 77
Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype
Lau, L., & David, G. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1565658 · Cited by 70
The Regulation of Cellular Functions by the p53 Protein: Cellular Senescence
Tonnessen-Murray, C. A., Lozano, G., & Jackson, J. G. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026112 · Cited by 70
“Interestingly, these senescent cells are cleared by the immune system, and failure to do so led to development of hepatocellular carcinoma (Kang et al. 2011).”
BackgroundSenescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance
Yin, K., Patten, D., Gough, S., de Barros Gonçalves, S., Chan, A., Olan, I., Cassidy, L., Poblocka, M., Zhu, H., Lun, A., et al. (2022) · Genes & Development · doi:10.1101/gad.349585.122 · Cited by 73
Schoetz, U., Klein, D., Hess, J., Shnayien, S., Spoerl, S., Orth, M., Mutlu, S., Hennel, R., Sieber, A., Ganswindt, U., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04454-5 · Cited by 74
“Given that SASP factors have been reported to shape immune cell recruitment and immune surveillance of tumors [40, 41], the question arises of how unSASPing therapy-induced senescence will affect the contribution of immune mechanisms to the overall treatment outcome.”
BackgroundSenescence and Apoptosis During in vitro Embryo Development in a Bovine Model
Ramos‐Ibeas, P., Gimeno, I., Cañón-Beltrán, K., Gutiérrez‐Adán, A., Rizos, D. V., & Gómez, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.619902 · Cited by 85
“The SASP allows senescent cells to secrete signaling molecules, generating a microenvironment, and activating the immune system to remove damaged or stressed cells (Kang et al., 2011; Sagiv et al., 2016).”
BackgroundMisawa, T., Tanaka, Y., Okada, R., & Takahashi, A. (2020) · Geriatrics & Gerontology International · doi:10.1111/ggi.13928 · Cited by 69
Cellular senescence in lymphoid organs and immunosenescence
Budamagunta, V., Foster, T. C., & Zhou, D. (2021) · Aging · doi:10.18632/aging.203405 · Cited by 67
“after their induction, which prevents them from significantly accumulating and causing adverse effects [18, 64].”
BackgroundDNA repair as a shared hallmark in cancer and ageing
Clarke, T. L., & Mostoslavsky, R. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13285 · Cited by 84
Liu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
“An initial recognition of the potential for T cells to be stimulated by SnCs came from studies of hepatocytes undergoing N-Ras G12V -driven senescence, where formation of SnCs induced CD4 + T cell-mediated tumor surveillance [29].”
BackgroundEGF promotes mammalian cell growth by suppressing cellular senescence
Alexander, P. B., Yuan, L., Yang, P., Sun, T., Chen, R., Xiang, H., Chen, J., Wu, H., Radiloff, D. R., & Wang, X. (2014) · Cell Research · doi:10.1038/cr.2014.141 · Cited by 78
Yanagi, S., Tsubouchi, H., Miura, A., Matsuo, A., Matsumoto, N., & Nakazato, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030503 · Cited by 80
The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity
White, S. M., Murakami, S., & Yi, C. (2019) · Oncogene · doi:10.1038/s41388-018-0649-6 · Cited by 75
Cellular senescence is a promising target for chronic wounds: a comprehensive review
Wang, Z., & Shi, C. (2020) · Burns & Trauma · doi:10.1093/burnst/tkaa021 · Cited by 82
“More importantly, there is convincing evidence that cells undergoing injury-induced senescence are usually cleared through immune-mediated removal in the late wound-healing process [36, 37, 49].”
BackgroundRosenberg, N., Van Haele, M., Lanton, T., Brashi, N., Bromberg, Z., Adler, H., Giladi, H., Peled, A., Goldenberg, D. S., Axelrod, J. H., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.07.029 · Cited by 72
Malavolta, M., Giacconi, R., Brunetti, D., Provinciali, M., & Maggi, F. (2020) · Cells · doi:10.3390/cells9040909 · Cited by 72
“Age-associated changes in CD4 T-cell functionality have been linked to chronic inflammation and decreased immunity [76] as well as to senescence immune surveillance [74,77].”
BackgroundHallmarks and Biomarkers of Skin Senescence: An Updated Review of Skin Senotherapeutics
Bulbiankova, D., Díaz‐Puertas, R., Álvarez‐Martínez, F. J., Herranz‐López, M., Barrajón‐Catalán, E., & Micol, V. (2023) · Antioxidants · doi:10.3390/antiox12020444 · Cited by 75
Premature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Tumor cell secretion of soluble factor(s) for specific immunosuppression
Kano, A. (2015) · Scientific Reports · doi:10.1038/srep08913 · Cited by 68
Embryonic senescent cells re-enter cell cycle and contribute to tissues after birth
Li, Y., Zhao, H., Huang, X., Tang, J., Zhang, S., Li, Y., Liu, X., He, L., Ju, Z., Lui, K. O., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0050-6 · Cited by 71
Golomb, L., Sagiv, A., Pateras, I. S., Maly, A., Krizhanovsky, V, Gorgoulis, V. G., Oren, M., & Ben-Yehuda, A. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.21 · Cited by 71
“The immune system has a crucial role in clearing senescent cells from damaged tissue.(50,74) Hence,”
BackgroundTranscriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence
Collin, G., Huna, A., Warnier, M., Flaman, J.-M., & Bernard, D. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0300-z · Cited by 71
Mária, J., & Ingrid, Ž. (2017) · Food & Function · doi:10.1039/c7fo00161d · Cited by 71
Aging and Chronic Liver Disease
Maeso-Díaz, R., & Gracia-Sancho, J. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1715446 · Cited by 68
Endothelial Senescence: A New Age in Pulmonary Hypertension
Culley, M. K., & Chan, S. Y. (2022) · Circulation Research · doi:10.1161/circresaha.121.319815 · Cited by 75
Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
Shreeya, T., Ansari, M. S., Kumar, P., Saifi, M., Shati, A. A., Alfaifi, M. Y., & Elbehairi, S. E. I. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1292053 · Cited by 84
Opportunities and challenges of targeting cGAS–STING in cancer
Lu, C., Wang, W., & Fu, Y. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-025-00894-9 · Cited by 79
“…(NF-κB) further lead to the release of type I IFN (IFN-I), cytokines, chemokines and additional factors as part of the senescence-associated secretory phenotype (SASP), which collectively induce antitumour immune responses mainly through T cell and natural killer (NK) cell activation 30,34,72,73 .”
Lauber, K., Brix, N., Ernst, A., Hennel, R., Krombach, J., Anders, H., & Belka, C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.047 · Cited by 75
Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer
Knocke, S., Fleischmann-Mundt, B., Saborowski, M., Manns, M. P., Kühnel, F., Wirth, T. C., & Woller, N. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.086 · Cited by 75
Self-citationYan, B. Y., Garcet, S., Gulati, N., Kiecker, F., Fuentes‐Duculan, J., Gilleaudeau, P., Sullivan-Whalen, M. M., Shemer, A., Mitsui, H., & Krueger, J. G. (2018) · Experimental Dermatology · doi:10.1111/exd.13805 · Cited by 72
Basak, S. K., Zinabadi, A., Wu, A. W., Venkatesan, N., Duarte, V. M., Kang, J. J., Dalgard, C. L., Srivastava, M., Sarkar, F. H., Wang, M. B., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4181 · Cited by 70
“There are reports indicating HPV mediated immune response playing a surveillance role through the removal of senescent cells by macrophages [39].”
BackgroundTargeting senescent cells: possible implications for delaying skin aging: a mini-review
Velarde, M. C., & Demaria, M. (2016) · Gerontology · doi:10.1159/000444877 · Cited by 69
Pyroptotic and non‐pyroptotic effector functions of caspase‐11
Khweek, A. A., & Amer, A. O. (2020) · Immunological Reviews · doi:10.1111/imr.12910 · Cited by 72
Telomeres and Cancer: Resolving the Paradox
Nassour, J., Schmidt, T. T., & Karlseder, J. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050420-023410 · Cited by 75
“On the one hand, it stimulates the growth of neighboring pretransformed cells (Coppé et al. 2010, Krtolica et al. 2001), and on the other hand, it participates in the clearance of senescent cells by attracting immune cells via a process called senescence surveillance (Kang et al. 2011).”
BackgroundKing, R. J., Shukla, S. K., He, C., Vernucci, E., Thakur, R., Attri, K. S., Dasgupta, A., Chaika, N. V., Mulder, S. E., Abrego, J., et al. (2022) · Oncogene · doi:10.1038/s41388-021-02132-6 · Cited by 75
“These data suggest decreased CD73 largely acts through a beneficial CD4 subtype, which could be through mechanisms such as CD4-dependent senescence surveillance or IFN-γ mediated anti-tumor responses [43, 44].”
BackgroundXue, H., Shiromoto, Y., Sakurai, M., Towers, M., Zhang, Q., Wu, S., Havas, A. P., Wang, L., Berger, S. L., Adams, P. D., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00959-z · Cited by 70
Khalil, R., Diab‐Assaf, M., & Lemaître, J.-M. (2023) · Cells · doi:10.3390/cells12060915 · Cited by 74
“Senescence induction by NRASG12V expression in hepatocytes leads to a dual release of both innate and adoptive immunological response, as CD4+ T cells collaborate with monocytes/macrophages to remove senescent hepatocytes [35].”
BackgroundCancer Immunosurveillance and Immunoediting by Natural Killer Cells
Gross, E., Sunwoo, J. B., & Bui, J. D. (2013) · The Cancer Journal · doi:10.1097/ppo.0000000000000005 · Cited by 64
“This opposition to previous reports(26,52) could be attributed to the method of senescence induction, which in the latter study relies on mutated oncogene administration for which immune response requires antigenspecific CD4 and monocytes.(51) Finally, it should be mentioned that although NK cells have been shown to m…”
BackgroundMethodT cells: Friends and foes in NASH pathogenesis and hepatocarcinogenesis
Ramadori, P., Kam, S., & Heikenwalder, M. (2022) · Hepatology · doi:10.1002/hep.32336 · Cited by 66
“Grohmann M, Wiede F, Dodd GT, Gurzov EN, Ooi GJ, Butt T, et al. Obesity drives STAT- 1- dependent NASH and STAT- 3- dependent HCC. Cell.”
BackgroundInfluentialSenescence in chronic wounds and potential targeted therapies
Wei, X., Li, M., Zheng, Z., Ma, J., Gao, Y., Chen, L., Peng, Y., Yu, S., & Yang, L. (2022) · Burns & Trauma · doi:10.1093/burnst/tkab045 · Cited by 73
“Senescence induced by the expression Nras (G12V) in the liver results in the presence of RAS-specific Th1 lymphocytes; thus, CD4(+) T cells collaborate with mononuclear macrophages to implement the elimination of senescent hepatocytes, demonstrating that senescent surveillance is vital for tumour suppression in vivo […”
Senescence and tissue fibrosis: opportunities for therapeutic targeting
O’Reilly, S., Tsou, P., & Varga, J. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.05.012 · Cited by 72
Zhang, L., Yang, Z., Ma, A., Qu, Y., Xia, S., Xu, D., Ge, C., Qiu, B., Xia, Q., Li, J., et al. (2014) · Hepatology · doi:10.1002/hep.26628 · Cited by 67
“(C) Tet-GADD45G-Sk-Hep1 cells transduced with control (vector) and SV40 LT were cultured for 4 days with (1) or without (2) GADD45G induction, then subjected to SA-b-gal staining.”
BackgroundMethodNF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2
Donatis, G. M. D., Pape, E. L., Pierron, A., Chéli, Y., Hofman, V., Hofman, P. M., Allegra, M., Zahaf, K., Bahadoran, P., Rocchi, S., et al. (2015) · Oncogene · doi:10.1038/onc.2015.331 · Cited by 70
Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells
Antonangeli, F., Soriani, A., Ricci, B., Ponzetta, A., Benigni, G., Morrone, S., Bernardini, G., & Santoni, A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1218105 · Cited by 64
“On the other hand, senescent cells can participate in tissue homeostasis during both embryogenesis and in adult tissues,(53,54) being cleared by the immune system.(55,56) The mechanisms through which senescent cells are recognized by the immune system are still largely obscure.”
BackgroundTargeting aging and age-related diseases with vaccines
Wu, R., Sun, F., Zhang, W., Ren, J., & Liu, G.-H. (2024) · Nature Aging · doi:10.1038/s43587-024-00597-0 · Cited by 66
“Studies have indicated that specific immunity to antigens expressed by premalignant senescent cells is part of tumor immune surveillance 152 .”
Metadata
- Authors
- Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., Weiss, S., Heikenwalder, M., Khan, S., Gil, J., Bruder, D., Manns, M., Schirmacher, P., Tacke, F., Ott, M., Luedde, T., Longerich, T., Kubicka, S., & Zender, L.
- Affiliations
- Helmholtz Centre for Infection Research (DE)
- Medizinische Hochschule Hannover (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Universitätsklinikum Aachen (DE)
- Imperial College London (GB)
- Heidelberg University (DE)
- Kreiskliniken Reutlingen (DE)
- Corresponding author
- Zender, Lars
- ORCID
- Venue
- Nature
- Published
- 2011-11
- Volume
- 479
- Issue
- 7374
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2042140414
- Cited by
- 1,621
- References
- 22
- Citations by year
- 2026: 93 · 2025: 127 · 2024: 154 · 2023: 140 · 2022: 148 · 2021: 139 · 2020: 137 · 2019: 103 · 2018: 110 · 2017: 99 · 2016: 84 · 2015: 78 · 2014: 72 · 2013: 84 · 2012: 49
- FWCI
- 45.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- oncogene-induced senescence, cellular senescence, hepatocytes, hepatocellular carcinoma, tumor surveillance, CD4+ T cells, tumor antigens, Th1 cells, monocytes/macrophages, tumor suppression, cancer prevention, cancer vaccines
- MeSH terms
- Animals, Antigens, Neoplasm, Carcinoma, Hepatocellular, Humans, Immunologic Surveillance, Liver, Liver Neoplasms, Phagocytosis, Precancerous Conditions, Genes, ras, CD4-Positive T-Lymphocytes, Mice, SCID, Cellular Senescence, Disease Progression, Cancer Vaccines, Hepatocytes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.